Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19

Hypercoagulability and thrombosis caused by coronavirus disease 2019 (COVID‐19) are related to the higher mortality rate. Because of limited data on the antiplatelet effect, we aimed to evaluate the impact of aspirin add‐on therapy on the outcome of the patients hospitalized due to severe COVID‐19....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Med Virol
Autors principals: Haji Aghajani, Mohammad, Moradi, Omid, Amini, Hossein, Azhdari Tehrani, Hamed, Pourheidar, Elham, Rabiei, Mohammad M., Sistanizad, Mohammad
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242852/
https://ncbi.nlm.nih.gov/pubmed/33913549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.27053
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars